Pfizer’s COVID-19 Vaccine Data In Young Children Could Place US FDA In Awkward Position Again

 
• By Derrick Gingery
  
Child vaccination
More Pfizer data on the efficacy of its COVID-19 vaccine in children younger than 5 is expected in the coming months. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet